
PPD appoints David Johnston as executive vice president
pharmafile | August 28, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | PPD, david johnston
Contract research organisation PPD has appointed Dr David Johnston as executive vice president of global laboratory services.
Johnston will direct the company’s lab services comprising bioanalytical, vaccines and biologics, current good manufacturing practice (cGMP) and central laboratories.
“David brings extensive leadership experience as well as scientific, medical and operational expertise,” said William Sharbaugh, chief operating officer at the firm.
“As pharmaceutical companies seek to increase productivity and reduce clinical development expense, I am confident David will help us drive innovative strategies as we continue integrating laboratory services with our Phase I-IV offerings to provide clients end-to-end value-chain capabilities.”
A biopharmaceutical industry veteran, Johnston joins PPD from LabCorp, where he served most recently as senior vice president and global head of the clinical trials business.
Related Content
Contract research news in brief
Icon offers $52m for CCH’s clinical services division, plus updates from PPD, Aptuit, Argenta, Quintiles …
Contract research news in brief
A round-up of recent developments in the contract research sector, including updates from Covance/GNS, AMRI, …
Contract research news in brief
Our round-up of news from the contract research sector includes PPD’s sales to a private …






